Company / Current Assets per Share
Kiniksa Pharmaceuticals International, plc Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.33
FY2025
5-year range
$3.63 / $7.33
FY2021-FY2025
Trend
+55.6%
vs FY2024
Sector context
#101 of 210
Health Care
What the data says
At $7.33, Kiniksa Pharmaceuticals International, plc's current assets per share ranks #101 of 210 in the Health Care sector. Current Assets per Share has increased for 4 consecutive years, from $3.63 in FY2021 to $7.33 in FY2025.
Based on SEC 10-K filings.
7.33 in FY2025 with a 5-year CAGR of +6.3%.
Improved from $4.03 to $7.33 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +23.1%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
#101 of 210 in Health CareTop 48% of 210This company $7.33 Sector average $134.38
▼
-94.5% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's current assets per share has grown for 4 consecutive years.
- In FY2025, current assets per share increased 55.6% year-over-year.
- Ranks #101 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.33 | +55.6% |
| FY2024 | $4.71 | +16.9% |
| FY2023 | $4.03 | +2.5% |
| FY2022 | $3.93 | +8.1% |
| FY2021 | $3.63 | -32.6% |
| FY2020 | $5.39 | +20.5% |
| FY2019 | $4.47 | -57.9% |
| FY2018 | $10.62 | -59.2% |
| FY2017 | $26.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026